Key result
Metabolic syndrome in pediatric renal transplant recipients was associated with a significantly higher prevalence of left ventricular hypertrophy compared to those without the syndrome (55.3% vs 32.0%, OR 2.6).
Why the study?
What is the prevalence of metabolic syndrome and its association with left ventricular hypertrophy in pediatric renal transplant recipients?
Observational (n=256)
Yes
What is the prevalence of metabolic syndrome and its association with left ventricular hypertrophy in pediatric renal transplant recipients?
Odds Ratio: 2.6 (95% CI 1.2–5.9)
Absolute Event Rate: 55.3% vs 32%
Metabolic syndrome is highly prevalent in pediatric kidney transplant recipients and its presence is strongly associated with left ventricular hypertrophy.
May support closer LVH monitoring in affected recipients; leaves open whether metabolic intervention alters progression.
Wilson AC, Greenbaum LA, Barletta GM, Chand D, Lin J-J, Patel HP, Mitsnefes M. High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients.Pediatr Transplantation 2010: 14: 52–60© 2009 John Wiley & Sons A/S. Abstract: The goal of this study was to estimate prevalence of the metabolic syndrome and its association with cardiac abnormalities in children with kidney transplant. A multi-center retrospective review of demographic, clinical, laboratory, and echocardiographic parameters at time of and at one-yr post-transplant was conducted in 234 pediatric recipients between 2000 and 2006. Eighty-eight patients (37.6%) met criteria for metabolic syndrome. Among 55 overweight patients, 40% had metabolic syndrome. Among 51 obese patients, 74.5% had metabolic syndrome. A total of 181 (71.0%) patients had complete data at both time points: prevalence of metabolic syndrome at time of transplant was 18.8%, compared with 37.0% at one-yr post-transplant (p < 0.0001). Among 147 patients without metabolic syndrome at time of transplant, 41 (27.9%) had developed metabolic syndrome by one-yr post-transplant. A total of patients from four centers had routine echocardiogram at one-yr post-transplant. LVH was significantly more common in those with metabolic syndrome (55%) than in those without (32%) (OR 2.6, 95% CI 1.2–5.9). In conclusion: metabolic syndrome is common at time of pediatric kidney transplant, and prevalence rises sharply at one-yr post-transplant. The presence of metabolic syndrome is strongly associated with LVH in these patients.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2009) conducted an observational in Pediatric end-stage renal disease post-renal transplant (n=256). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Left ventricular hypertrophy (LVH) (OR 2.6, 95% CI 1.2-5.9). Metabolic syndrome in pediatric renal transplant recipients was associated with a significantly higher prevalence of left ventricular hypertrophy compared to those without the syndrome (55.3% vs 32.0%, OR 2.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: